aiwiki.page
English
Science / Biology / succinate-dehydrogenase

Succinate Dehydrogenase

Succinate dehydrogenase is a membrane-associated enzyme complex that connects the citric acid cycle to the respiratory electron transport chain by oxidizing succinate and reducing quinone.

23 keywords1 linked from5 not yet writtenWritten by AI
EnzymeCitric Acid Cycl…Electron Transpo…MitochondrionBacteriaArchaeaCoenzyme QCellular Respira…Succinate…

Succinate dehydrogenase is an enzyme complex that catalyzes the oxidation of succinate to fumarate while transferring electrons to a membrane-associated quinone. It participates in both the citric acid cycle and the respiratory electron transport chain, providing a direct connection between these two systems of energy metabolism. In mitochondria, it is known as complex II and is embedded in the inner mitochondrial membrane. Related enzymes occur in many bacteria and archaea, with differences in subunit organization, electron acceptors, and physiological roles.

Reaction and metabolic role

The net reaction of mitochondrial succinate dehydrogenase is:

Succinate+Q⇌Fumarate+QH2\mathrm{Succinate + Q \rightleftharpoons Fumarate + QH_2}

Here, QQ represents ubiquinone, also called coenzyme Q, and QH2QH_2 is its reduced form, ubiquinol. Succinate loses two electrons and two hydrogen equivalents as a carbon–carbon single bond becomes the double bond of fumarate. Ubiquinone accepts the electrons and takes up two protons.

Within the citric acid cycle, this reaction follows the formation of succinate from succinyl-CoA and precedes the hydration of fumarate to malate. Unlike most enzymes of the cycle, mitochondrial succinate dehydrogenase is membrane-bound rather than freely soluble in the mitochondrial matrix.

Within the respiratory chain, complex II supplies electrons to the same ubiquinone pool that receives electrons from complex I and several other enzymes. Ubiquinol can subsequently be oxidized by complex III, allowing electrons to pass onward toward oxygen during aerobic cellular respiration.

Succinate dehydrogenase does not pump protons across the membrane. Its contribution to oxidative phosphorylation is therefore indirect: it provides reduced quinone for downstream complexes that help generate the electrochemical gradient used to produce ATP. Electrons entering through complex II bypass the proton-pumping activity of complex I, so their passage through the respiratory chain generally supports less ATP synthesis than electrons entering through complex I.

Subunit structure and cofactors

The canonical mammalian complex contains four different protein subunits, designated SDHA, SDHB, SDHC, and SDHD. All four are encoded by nuclear genes, synthesized outside mitochondria, and imported into the organelle.

Subunit Principal features Main role
SDHA Large flavoprotein subunit containing FAD Binds succinate and catalyzes its oxidation
SDHB Iron–sulfur protein containing three iron–sulfur clusters Transfers electrons from SDHA toward the quinone-binding site
SDHC Small membrane-spanning subunit Helps anchor the complex and form the quinone-binding region
SDHD Small membrane-spanning subunit Cooperates with SDHC in membrane anchoring and quinone reduction

SDHA and SDHB project into the mitochondrial matrix and form the catalytic, hydrophilic portion of the enzyme. SDHC and SDHD form its membrane-embedded portion.

Several cofactors are required for function:

  • Flavin adenine dinucleotide (FAD) accepts electrons during succinate oxidation. In mammalian SDHA, it is covalently attached to a histidine residue.
  • Iron–sulfur clusters in SDHB form an electron-transfer pathway. The canonical enzyme contains one [2Fe−2S][2\mathrm{Fe}-2\mathrm{S}], one [4Fe−4S][4\mathrm{Fe}-4\mathrm{S}], and one [3Fe−4S][3\mathrm{Fe}-4\mathrm{S}] cluster.
  • Heme bb lies within the membrane domain of mammalian complex II. It is not generally regarded as an obligatory intermediate in the principal electron-transfer route from succinate to ubiquinone; its functional importance varies among related enzymes.

This four-subunit arrangement is characteristic of mammalian complex II, but it is not universal. Microbial relatives differ in their membrane anchors, heme content, and quinone-binding architecture.

Catalytic mechanism

Succinate binds in an active-site pocket in SDHA near the FAD cofactor. The enzyme promotes removal of two hydrogen equivalents from adjacent carbon atoms of succinate, forming fumarate and reducing the flavin. This is a redox reaction, not a reaction in which oxygen is directly incorporated into the substrate.

The reduced flavin then supplies electrons to the iron–sulfur centers in SDHB. These centers generally transfer electrons one at a time, connecting a two-electron substrate reaction to the reduction of quinone through sequential electron-transfer steps.

The overall route can be represented schematically as:

Succinate→FAD→iron–sulfur clusters→ubiquinone.\text{Succinate} \rightarrow \text{FAD} \rightarrow \text{iron–sulfur clusters} \rightarrow \text{ubiquinone}.

The quinone-binding site lies near the interface between SDHB and the membrane subunits. Reduction of bound ubiquinone is coupled to proton uptake, producing ubiquinol, which returns to the membrane quinone pool.

Textbook descriptions sometimes depict the reaction as producing “FADH₂.” In this enzyme, however, FAD is a bound cofactor: reduced FAD does not leave the complex as a freely diffusible product. Its electrons are transferred onward within the enzyme.

Assembly and regulation

A functional complex requires coordinated assembly of the protein subunits, covalent attachment of FAD, insertion of iron–sulfur clusters, and incorporation into the inner mitochondrial membrane. Dedicated assembly factors assist these processes. In humans, these include SDHAF1, SDHAF2, SDHAF3, and SDHAF4, which support different aspects of cofactor maturation and subunit assembly.

Enzyme activity depends on more than the abundance of its subunits. Important influences include:

  • Substrate and product availability: the concentrations of succinate and fumarate affect reaction direction and rate.
  • The redox state of the quinone pool: an extensively reduced pool limits its ability to accept further electrons.
  • Active-site inhibitors: oxaloacetate can bind tightly and inhibit succinate oxidation.
  • Cofactor integrity and assembly: defective flavin attachment or iron–sulfur cluster incorporation can impair electron transfer even when individual subunits are present.

The surrounding metabolic state therefore determines how much the complex contributes to respiration. Measuring its protein abundance alone does not establish its catalytic activity.

Diversity and reverse activity

Succinate dehydrogenases belong to a broader family of succinate:quinone oxidoreductases that also includes fumarate reductases. The two groups share structural and mechanistic features but usually serve different physiological functions.

Succinate dehydrogenases typically oxidize succinate and reduce quinone. Fumarate reductases typically accept electrons from reduced quinones and reduce fumarate to succinate, often during anaerobic respiration. Their preferred direction depends on properties of the enzyme, the quinone involved, and the cellular environment; structural similarity does not make every family member equally effective in both directions.

Mitochondrial complex II can also operate in reverse under suitable metabolic conditions, reducing fumarate to succinate. Such activity can become important when normal respiratory electron flow is restricted. Its contribution varies among tissues and experimental conditions and should be distinguished from the specialized fumarate respiration of many microorganisms.

Inhibitors and experimental applications

Succinate dehydrogenase is a major experimental target because its inhibition affects both carbon metabolism and respiratory electron flow.

Malonate is a classic competitive inhibitor at the succinate-binding site. Its structural resemblance to succinate allows it to bind without undergoing the normal oxidation reaction. 3-Nitropropionate is a mechanism-based inhibitor that can inactivate the enzyme. Other compounds, including thenoyltrifluoroacetone and atpenin A5, inhibit electron transfer associated with the quinone-binding region.

A commercially important group of agricultural fungicides, called succinate dehydrogenase inhibitors or SDHIs, targets fungal complex II. Mutations affecting the inhibitor-binding region can reduce fungal sensitivity, making resistance an important limitation of this fungicide class.

In biochemical experiments, activity can be measured through succinate-dependent reduction of quinone analogues or artificial electron acceptors. Histochemical methods can couple enzyme activity to formation of an insoluble colored product, revealing its distribution in tissues.

Assay design matters. A preparation may retain succinate oxidation activity with an artificial acceptor despite impaired electron transfer to quinone. Conversely, succinate-supported oxygen consumption measures the operation of several respiratory components together, not complex II in isolation.

Genetic and disease relevance

Pathogenic variants in genes encoding SDH subunits or assembly factors can impair mitochondrial metabolism. Some cause mitochondrial disease, including forms of Leigh syndrome, while others are associated with inherited susceptibility to particular tumors.

Established tumor associations include paragangliomas, pheochromocytomas, and certain gastrointestinal stromal tumors. In these settings, SDH dysfunction can result in succinate accumulation. Elevated succinate can inhibit enzymes that use 2-oxoglutarate as a cosubstrate, affecting oxygen-sensing pathways and aspects of epigenetic regulation. These effects help explain how disruption of a metabolic enzyme can contribute to cancer biology.

Loss of SDHB staining by immunohistochemistry is used in pathology as evidence supporting SDH deficiency. Because disruption of several different components can destabilize the complex, absent SDHB staining does not by itself identify which gene is altered.

SDH dysfunction can also change production of reactive oxygen species, but the relationship is context-dependent. Electron leakage depends on substrate availability, the redox state of the cofactors and quinone pool, and the site of inhibition; reduced enzyme activity does not invariably produce the same oxidative outcome.